Synthesis of novel heterocyclic Quinolone compound for anti -tubercular activity

Main Article Content

Rahul K. Godge
Rahul Kunkulol


In last few decades, though significant progress has been made in the treatment and control strategies of tubercular infections by introducing new diagnostic and monitoring tools and combination therapy, it still continues to be severe problem. The need of study was only because of there are many drugs in market to treat infection but most of the drugs are showing resistance because of the same it is difficult to treat the infection. In this study we chosen quinolone nucleus for study and over it.  Thus with the aim of developing novel molecule with improved potency for treating Mycobacterium tuberculosis H37Rv strain infections and with decreased probability of developing drug resistance. Methodology: The synthesis of Quinolone derivatives, starting from substituted aniline and ethyl acetoacetate, by conventional organic reaction and results of investigations of their anti-mycobacterial activity. Results: MICs of the synthesized compounds are compared with existing drugs Cytotoxicity. The substituted quinolones are synthesized by taking mixture of 7-substituted-2-(3-chloro-2-oxopropyl) quinolin-4(1H)-one and different secondary amines.  Many compounds have shown promising activity while some were inactive. Conclusion: It was found that Compound A1, A3, B1, B3, have shown promising anti tubercular activity whereas compound A2, A4,B2,B4 were showing moderate anti tubercular activity  against std. Streptomycin. 

Article Details

How to Cite
Godge, R. K., & Kunkulol, R. (2018). Synthesis of novel heterocyclic Quinolone compound for anti -tubercular activity. International Journal of Clinical and Biomedical Research, 4(3), 44-49.
Original Research Articles


1. Ania AE, Idokob J, Dalyopc Y B. Pitmangd SLT. Article title. Roy. Soci. Trup. Med. 2009;103:67.
2. Said HA, Abdel GS, Morlock G, Cooksey RC. Article title Int. J. Infect. Dis.2009;,13, 673.
3. Antimicrobial - Definition from the Merriam-Webster Online Dictionary. Retrieved 2009-05-02.
4. John HK, John MB. Wilson and Gisvold’s Text book of Organic medicinal and Pharmaceutical Chemistry. 11th Edition, Philadelphia: Lippincott Williams and Wilkins; 2004: 299-301.
5. Rang HP, Dale MM, Ritter JM, Moore P K. Pharmacology. 5th Edition, New Delhi: Elsevier India Pvt Ltd; 2003: 667-72.
6. Silverstein SC, Stienman RM, Cahhn ZA. Endocytosis. Ann. Rev. Biochem. 1977; 46: 669-72.
7. Stephonson TJ. Inflammation. In: Underwood JCE. General and Systemic Pathology. 4th Edition, London: Churchill Livingstone. 2004: 201-22.
8. Baxter JD, Rosseau GG. Glucocoticoid hormone action: an overview. Monogram. Endocrinal. 1979; 12:1-24.
9. Vinay Kumar, Cotran RD, Robbins S. Basic Pathology. 6th Edition, Bangalore: Prism Book Pvt Ltd; 1997: 25-46.
10. Hardman JG, Limbird LE. Goodman Gilman’s The Pharmacological Basis of Therapeutics. 10th edition, New York: McGraw-Hill Medical Publishing Division; 2001: 687-730.
11. John HK, John MB. Wilson and Gisvold’s Text book of Organic medicinal and Pharmaceutical Chemistry. 11th Edition, Philadelphia: Lippincott Williams and Wilkins; 2004: 818-22.
12. Nugteren DH, Hazelhof E. Isolation and properties of intermediates in prostaglandin biosynthesis. Biochem. Biophysics. Acta 1973; 326: 448-461
13. Chun MW, Olmstead KK, Choi YS, Chong OL, Chong-Kyo L, Joong HK, et al. Synthesis and biological activities of truncated acridone: Structure-activity relationship studies of cytotoxic 8-hydroxy-4-quinolone. Bioorganic & Medicinal Chemistry Letters. 1997;7(1): 789-92.
14. Hong C, Kim S, Kim Y. Novel 5-amino-6-methylquinolone anti-bacterial: A new class of non-6-fluoroquinolones. Bioorganic & Med. Chemistry Letters 1997;7(14):1875-1878.
15. Srivastava S, Srivastava SK , Shukla A , Chauhan P , Purlet S. Synthesis and the amides of methemoglobin toxicity of 6/7 mono or disubstituted quinolone. Bioorganic & Med. Chemistry Letters 1999 9: 25-30.
16. Masahiko H, Hiroto K, Tetsushi K, Tomio K , Tomoaki K. Synthesis and anti-HIV activity of arylpiperazinyl fluoroquinolones: a new class of anti-HIV agents. Bioorganic & Med. Chemistry Letters.1999; 9: 3063-3068.
17. Fukui H, Shibata T, Naito T, Nakano J, Maejima T, Senda H, et al. Synthesis and Antibacterial Activity of Novel 7-(3-Substituted-3 or 4-trifluoromethyl- 1- pyrrolidinyl)-8-methoxyfluoroquinolones. Bioorganic & Med. Chemistry Letters 1998; 8: 2833-38.
18. Robert J, Kerns RJ, Michael J, Glenn WR, Vaka F, Richard GR, et al. Piperazinyl-Linked Fluoroquinolone Dimers Possessing Potent Antibacterial Activity Against Drug-Resistant Strains of Staphylococcus aureus. Bioorganic & Med. Chemistry Letters 2003; 13: 1745–49.
19. Foroumadi A, Soltani F, Moshafi MH, Ashraf-Askari R. Synthesis and in vitro antibacterial activity of some N-(5-aryl-1,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives. II. Farmaco 2003; 58: 1023-28.
20. Xia Y, Yang Z, Peng X, Bastow KF, Nakanishi Y, Priya N.. Antitumor Agents. Part 226: Synthesis and Cytotoxicity of 2-Phenyl-4-quinolone Acetic Acids and Their Esters. Bioorganic & Med. Chemistry Letters 2003; 13: 2891–93.
21. Scott HW, Marianne CTG, Murali D, Shen Z, Pitts WJ, Junqing G, et al. Novel inhibitors of IMPDH a highly potent and selective quinolone-based series. Bioorganic & Med. Chemistry Letters 2003; 13(3), 543-46.
22. Piyasena H, Nathan C, Min D, Joanne T, Christopher G, Boissard, et al. The synthesis and structure–activity relationships of 3-amino-4-benzylquinolin-2-ones: discovery of novel KCNQ2 channel openers. Bioorganic & Med. Chemistry Letters 2004; 14: 1615–1618.
23. Qun L, Woods KW, Wang W, Nan-Horng L, Claiborne A, Wen-zhen G. Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiolfarnesyl transferase inhibitors. Bioorganic & Med. Chemistry Letters 2005; 15: 2033–39.
24. Sriram D, Yogeeswari P, Basha JS, Radhab DR, Nagaraja V. Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives. Bioorganic & Medicinal Chem. 2005; 13: 5774–78.
25. Lucero BA, Gomes CR, Frugulhetti IC, Faro LV, Alvarenga L, Maria C. Synthesis and anti-HSV-1 activity of quinolonic acyclovir analogues. Bioorganic & Med. Chemistry Letters 2006; 11: 1010–13.
26. Farhanullah, Yeon Kim S, Yoon EJ, Choi EC, Sunghoon K, et al. Design and synthesis of quinolinones as methionyl-tRNA synthetase inhibitors. Bioorganic & Medicinal Chem. 2006; 14: 7154–59
27. Sephra N. Rampersad. Multiple Applications of Alamar Blue as an Indicator of metabolic Function and Cellular Health in Cell Viability Bioassays. Sensors (Basel). 2012;12(9): 12347–12360.